News

Rosenman Institute

Congratulations to Zeto and its CEO/Founder Aswin Gunasekar. The FDA has recently approved their product for clinical use. Zeto's "dry electrode" headset, is the first of its kind to obtain FDA approval, enables doctors to obtain EEGs quickly and conveniently...

Zeto Raises Series A Funding to Accelerate Commercialization Efforts of its Easy Use Electroencephalography (EEG) Headset and Software Platform

SANTA CLARA, Calif., March 10, 2020 /PRNewswire/ -- Zeto, Inc., a privately held medical technology company that is transforming the Electroencephalography (EEG) experience for healthcare, today announced that it has raised $7.3 million in Series A financing led by Seraph...

ZETO: Sensing Improvement in Neurological Data Processing

EEG is the gold standard for observing and characterizing neural activity, but patients are subject to lengthy and uncomfortable preparation for scans, and interpretation is subjective to the physician who reads it. Zeto has introduced a device designed for patient...

Tomorrow’s World – ZETO

Learn about ZETO and explore a whole new world of EEG.

Solving the challenges of living with epilepsy in a timeframe that matters

zEEG by ZETO – Making EEGs Easier to Perform. An electroencephalogram (EEG) measures brain activity. Since 1924, the EEG reading procedure in the hospital has not significantly changed. The process normally entails a trained technician measuring the head, sorting Source...

The Next-Gen Electroencephalography – Zeto

Zeto is a medical technology startup transforming the way EEG (Electroencephalography) is done at hospitals. They are solving a problem that has remained unsolved since EEG was invented in 1924, that is, an archaic, tedious approach that consumes time, requires...

Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use

Zeto EEG provides a better, more convenient experience to patients and technicians and faster turnaround time to hospitals than current technology SANTA CLARA, Calif., May 29, 2018 /PRNewswire/ -- Zeto, Inc., a privately held medical technology company transforming the way...

Dry Electrode Headset EEG Receives FDA Approval for Clinical Use

In April 2018, the U.S. Food and Drug Administration (FDA) approved Zeto, Inc.'s "dry electrode" EEG (electroencephalogram) headset and its software platform for clinical use. The Zeto headset, called zEEG, is easy to wear and does not need any preparation....

New Therapy Funding

The mission of the Epilepsy Therapy Project of the Epilepsy Foundation is to accelerate ideas into new therapies for people living with epilepsy and seizures. Zeto is developing a turnkey solution for Routine EEG tests by providing EEG to facilities...

Shark Tank Presentation Video: Instant EEG to Better Diagnose and Manage Epilepsy

Aswin Gunasekar, founder of Zeto Inc., presents his team's instant EEG project at the 2016 Epilepsy Foundation Shark Tank competitionntries around the world.

Shark Tank Competition 2016

The Epilepsy Foundation’s Shark Tank competition seeks to advance innovative ideas in epilepsy and seizure treatment and care. The winners will use their prize to accelerate their innovation to the next phase of development and closer to being accessible to...